Braveheart Bio targets up to $318.8M in US IPO
Braveheart Bio is a company that makes medicines. It wants to sell shares to the public in the US. This is called an initial public offering (IPO). The company will list on a US stock exchange and raise up to $318.8 million. This is a lot of money.
5.9Significance
1 source6.0Source trust